INFLIXIMAB TROUGH LEVELS AND DISEASE ACTIVITY PREDICT EARLY CLINICAL RESPONSE IN PATIENTS WITH AXIAL SPONDYLOARHTRITIS

被引：2
|
作者：
Martinez-Feito, Ana [1 ]
Plasencia, Chamaida [2 ]
Hernandez-Breijo, Borja [3 ]
Navarro-Compan, Victoria [2 ]
Peiteado, Diana [2 ]
Villalva, Alejandro [2 ]
Nuno, Laura [2 ]
Monjo, Irene [2 ]
Diego, Cristina [1 ]
Pascual-Salcedo, Dora [3 ]
Balsa, Alejandro [2 ]
机构：
[1] Hosp La Paz Madrid, Immunol, Madrid, Spain
[2] Hosp La Paz Madrid, Rheumatol, Madrid, Spain
[3] IdiPAZ, Immunorheumatol Res Grp, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.3984
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0399
引用
收藏
页码：885 / 885
页数：1
相关论文
共 50 条
  • [21] Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment response
    Ben-Horin, Shomron
    Chowers, Yehuda
    GUT, 2012, 61 (02) : 322 - 322
  • [22] SERUM TROUGH LEVELS OF ADALIMUMAB AND INFLIXIMAB INVERSELY CORRELATE WITH DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY ARTHRITIS
    Wong, P.
    Bowling, A.
    Ford, E.
    Freeman, D.
    Bagga, H.
    Langguth, D.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 15 - 16
  • [23] Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
    Sekhri, Shaina
    Rao, Bharat
    Mohananey, Akanksha
    Beniwal-Patel, Poonam
    Bruss, Alexandra
    Stein, Daniel J.
    Yarur, Andres J.
    BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [24] CLINICAL USE OF INFLIXIMAB TROUGH LEVELS DURING MAINTENANCE IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    van Hoeve, Karen
    Hoffman, Ilse
    Dreesen, Erwin
    Ferrante, Marc
    Ann, Gils
    Vermeire, Severine
    GASTROENTEROLOGY, 2018, 154 (06) : S1042 - S1042
  • [25] Loss of Response in IBD Patients on Infliximab Treatment: Assay of Infliximab Trough Levels and Total Antibodies to Infliximab
    Guidi, Luisa
    Marzo, Manuela
    Pugliese, Daniela
    Felice, Carla
    Andrisani, Gianluca
    Papa, Alfredo
    Rapaccini, Gian Ludovico
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2015, 148 (04) : S857 - S857
  • [26] Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease
    Bodini, Giorgia
    Giannini, Edoardo G.
    Savarino, Vincenzo
    Del Nero, Lorenzo
    Lo Pumo, Sara
    Brunacci, Matteo
    De Bortoli, Nicola
    Jain, Anjali
    Tolone, Salvatore
    Savarino, Edoardo
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (05) : 452 - 456
  • [27] Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis
    Moore, Hillary
    Dolce, Pasquale
    Devas, Nina
    Baldassano, Robert
    Martinelli, Massimo
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (04) : 425 - 435
  • [28] Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis
    Wolbink, GJ
    Voskuyl, AE
    Lems, WF
    de Groot, E
    Nurmohamed, MT
    Tak, PP
    Dijkmans, BAC
    Aarden, L
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) : 704 - 707
  • [29] Early monitoring of infliximab serum trough levels predicts long-term therapy failure in patients with axial spondyloarthritis
    Martinez-Feito, A.
    Navarro-Compan, V
    Hernandez-Breijo, B.
    Olariaga-Merida, E.
    Peiteado, D.
    Villalba, A.
    Nuno, L.
    Monjo, I
    Diego, C.
    Pascual-Salcedo, D.
    Nozal, P.
    Balsa, A.
    Plasencia-Rodriguez, C.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, 51 (02) : 102 - 109
  • [30] The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis
    van den Bemt, Bart J. F.
    den Broeder, Alfons A.
    Wolbink, Gert-Jan
    van den Maas, Aatke
    Hekster, Yechiel A.
    van Riel, Piet L. C. M.
    Benraad, H. Bart
    van den Hoogen, Frank H. J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (06) : 939 - 945
12345